Any feedback?
Literature summary for 3.4.21.109 extracted from
- Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract (2005), World J. Gastroenterol., 11, 6202-6207.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | expression of serine protease SNC19/matripase and hepatocyte growth factor is decreased in gastrointestinal cancer tissues compared to their normal counterparts, decreased expression may correlate with invasion and lymph node metastasis | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| hepatocyte growth factor activator inhibitor-1 | - |
Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| gastrointestinal tract | in cancer tissue the expression of serine protease SNC19/matripase and hepatocyte growth factor activator inhibitor-1 is significantly lower than in the corresponding adjacent normal tissue, the ratio, however, shows no difference between normal and malingant tissue | Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| serine protease SNC19/matripase | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
